ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Immunology
インパクトファクター: 1.352 5年インパクトファクター: 3.347 SJR: 1.022 SNIP: 0.55 CiteScore™: 2.19

ISSN 印刷: 1040-8401
ISSN オンライン: 2162-6472

巻:
巻 39, 2019 巻 38, 2018 巻 37, 2017 巻 36, 2016 巻 35, 2015 巻 34, 2014 巻 33, 2013 巻 32, 2012 巻 31, 2011 巻 30, 2010 巻 29, 2009 巻 28, 2008 巻 27, 2007 巻 26, 2006 巻 25, 2005 巻 24, 2004 巻 23, 2003 巻 22, 2002 巻 21, 2001 巻 20, 2000 巻 19, 1999 巻 18, 1998 巻 17, 1997 巻 16, 1996 巻 15, 1995 巻 14, 1994

Critical Reviews™ in Immunology

発行物を購入する $264.00 巻 15, 1995 発行 3-4

DOI: 10.1615/CritRevImmunol.v15.i3-4

目次:

Lipopolysaccharide Binding Protein Participation in Cellular Activation by LPS
G. L. Su, R. L. Simmons, S. C. Wang
pages 201-214
DOI: 10.1615/CritRevImmunol.v15.i3-4.10
Expression and Function of Fc Receptors in the Thymus
Georges Leclercq , Jean Plum
pages 215-233
DOI: 10.1615/CritRevImmunol.v15.i3-4.20
T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
Anette Gjorloff Wingren, Eduardo Parra, Mikael Varga, Terje Kalland, Hans-Olov Sjogren, Gunnar Hedlund, Mikael Dohlsten
pages 235-253
DOI: 10.1615/CritRevImmunol.v15.i3-4.30
IgM-Mediated B Cell Apoptosis
Mitsufumi Mayumi, Yusei Ohshima, Daisuke Hata, Kwang-Myong Kim, Toshio Heike, Kenji Katamura, Kenshi Furusho
pages 255-269
DOI: 10.1615/CritRevImmunol.v15.i3-4.40
Interactions of Migrating T Lymphocytes, Inflammatory Mediators, and the Extracellular Matrix
Ofer Lider, Rami Hershkoviz, Sylvia G. Kachalsky
pages 271-283
DOI: 10.1615/CritRevImmunol.v15.i3-4.50
T Lymphocyte Migration: The Influence of Interactions via Adhesion Molecules, the T Cell Receptor, and Cytokines
Dan Hauzenberger, Julius Klominek, Sten-Erik Bergstrom, Karl-Gosta Sundqvist
pages 285-316
DOI: 10.1615/CritRevImmunol.v15.i3-4.60
The Mucosal Adjuvant Activities of ADP-Ribosylating Bacterial Enterotoxins
Denis P. Snider
pages 317-348
DOI: 10.1615/CritRevImmunol.v15.i3-4.70
The Role of T Cells in Kawasaki Disease
Jaime de Inocencio , Raphael Hirsch
pages 349-357
DOI: 10.1615/CritRevImmunol.v15.i3-4.80
Mechanisms of Lysis by Cytotoxic T Cells
Eric A. Atkinson , R. Chris Bleackley
pages 359-384
DOI: 10.1615/CritRevImmunol.v15.i3-4.90
Subject Index-Volume 15
385 pages
DOI: 10.1615/CritRevImmunol.v15.i3-4.100
Author Index-Volume 15
387 pages
DOI: 10.1615/CritRevImmunol.v15.i3-4.110

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling